featured

Use this feature to promote an article to the front page.

Scoring Goals for Autism 2014 Video

Abstract: 

Can't get enough soccer these days? Check out the new awesome video from Scoring Goals for Autism 2014!

Scoring Goals for Autism 2014

Motor Deficits Match Autism Severity

Source: 
Simons Foundation Autism Research Initiative
Date Published: 
June 20, 2014
Abstract: 

The severity of core autism symptoms in young children goes hand in hand with the degree of the children’s difficulty with motor tasks, according to a study published in the April issue of the Adapted Physical Activity Quarterly. Early interventions, such as therapies that target social and communicative behavior, may alter autism’s course. Building strong motor skills may help children with autism develop better social and communicative skills, especially in physically demanding play, the researchers say.

For Flagging Autism Risk, Using Two Tests is Best Option

Source: 
Simons Foundation Autism Research Initiative
Date Published: 
June 20, 2014
Abstract: 

The average child with autism is 18 months old before his or her parents first begin to be concerned. Given the importance of early intervention, it’s crucial that parents and doctors both catch on to the symptoms as soon as possible. A study published in European Child and Adolescent Psychiatry finds that two autism screens are better than one at identifying toddlers who need specialized clinical services. These screens, such as the Modified Checklist for Autism in Toddlers (M-CHAT) and the Early Screening of Autistic Traits (ESAT), are used not to diagnose autism, but rather to identify children who need more specialized attention — for example, from a child psychiatrist or a behavioral therapist.

Autism Science Foundation Request for Applications: 2014 Research Enhancement Mini-Grants

Source: 
The Autism Science Foundation
Date Published: 
June 24, 2014
Abstract: 

The Autism Science Foundation today released its request for applications for 2014 Research Enhancement Mini-Grants. ASF is inviting applications for grants of up to $5,000 to enable researchers to expand the scope or increase the efficiency of existing grants, or to take advantage of changes or findings that have occurred in or around an existing project that warrant more funding. Applications must be received by September 12, 2014.

 Read the full RFA here
 

Neurodevelopmental Disorders and Prenatal Residential Proximity to Agricultural Pesticides

Source: 
University of California-Davis
Date Published: 
June 23, 2014
Abstract: 

A study out of the University of California Davis found that women who live near farmland where pesticides are applied are 60 percent more likely to give birth to a child with autism or other developmental delays. In the study, the association was stronger for women exposed during their second or third trimester. The study looked at three categories of pesticides: organophosphates, pyrethroids and carbamates; all three were found to have associations with ASD or other developmental delays.

Evidence of Reproductive Stoppage in Families With Autism Spectrum Disorder

Source: 
JAMA Psychiatry
Date Published: 
June 18, 2014
Abstract: 

Research published in JAMA Psychiatry shows that parents who have a child with autism are about a third less likely to choose to continue having children compared to parents who do not have a child with ASD. In the study, this "reproductive stoppage" did not occur until the child started showing symptoms or received a diagnosis of ASD. This led researchers to conclude that it was a conscious decision to stop having children, rather than another factor such as fertility problems.

Reversal of Autism-Like Behaviors and Metabolism in Adult Mice with Single-Dose Antipurinergic Therapy

Source: 
Translational Psychiatry
Date Published: 
June 17, 2014
Abstract: 

Researchers at UC San Diego have discovered that suramin, a drug that was originally developed to treat African sleeping sickness, reverses autism-like social behaviors in mice. This study proposes that the social difficulties and metabolism issues found in individuals with ASD could be improved with the use of suramin — even in adults. While suramin has not been tested in humans, these findings could direct future research for autism therapies.

Should We Believe the Centers for Disease Control and Prevention’s Autism Spectrum Disorder Prevalence Estimates?

Source: 
Autism: The International Journal of Research and Practice
Date Published: 
July 2014
Abstract: 

Autism: The International Journal of Research and Practice has published an important and interesting new editorial by Dr. David Mandell and Dr. Luc Lecavalier that challenges the methods the CDC uses to collect and publish autism prevalence data, now at 1 in 68.

In Autism, Brain Shows Unusual Thinning Throughout Life

Source: 
Simons Foundation Autism Research Initiative
Date Published: 
June 5, 2014
Abstract: 

The cortex, the outer layer of the brain, grows rapidly in early childhood in people with autism and thins differently with age than it does in controls, two new studies report. Together, the studies support the theory that the brain grows too quickly and shrinks too soon in people with autism.

Costs of Autism Spectrum Disorders in the United Kingdom and the United States

Source: 
JAMA Pediatrics
Date Published: 
June 9, 2014
Abstract: 

Having an accurate estimate of the economic cost of autism has many implications for service and system planning. The most recent estimates are almost a decade old and had to rely on many estimates for which there were no good data. Today in JAMA Pediatrics, researchers, including ASF Scientific Advisory Board member Dr. David Mandell, updated older estimates and further expanded our understanding of costs by estimating them for two countries: the United States and the United Kingdom. They also estimated costs separately for children and adults, and for individuals with autism with and without intellectual disability. To estimate costs, researchers reviewed the literature on related studies, conducting a thorough search of studies that estimated direct costs, such as education and service use costs, as well as indirect costs, such as lost wages for family members and the individual with autism. They found that for individuals with autism and intellectual disability, the average lifetime cost was $2.4 million in the US and $2.2 million in the UK. For individuals without intellectual disability, the average cost was $1.4 million in both the US and the UK. For children with autism, the largest costs were for special education and parents’ lost wages. For adults with autism, the largest costs were residential care and lost wages.

Click here for the full article.